Clinical trialNCT00096213CompletedPhase 2Interventional

S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone

SponsorSWOG Cancer Research NetworkEnrollment60Sarcoma

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

RATIONALE: Intralesional resection is a less invasive type of surgery for chondrosarcoma of the bone and may have fewer side effects and improve recovery. PURPOSE: This phase II trial is studying how well intralesional resection works in treating patients with low-grade chondrosarcoma of the bone.

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

Edward Cheng, MD
Masonic Cancer Center, University of Minnesota
Study Chair
clinicaltrials.gov ↗
Janet S. Biermann, MD
University of Michigan Rogel Cancer Center
Study Chair
clinicaltrials.gov ↗
R. Lor Randall, MD, FACS
University of Utah
Study Chair
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

23 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Aurora, Colorado, United States
University of Florida Shands Cancer Center
Gainesville, Florida, United States
University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
William Beaumont Hospital - Royal Oak Campus
Royal Oak, Michigan, United States
University of New Mexico Cancer Research and Treatment Center
Albuquerque, New Mexico, United States
Akron City Hospital
Akron, Ohio, United States
Oregon Health & Science University Cancer Institute
Portland, Oregon, United States
Presbyterian Hospital of Dallas
Dallas, Texas, United States
Huntsman Cancer Institute at University of Utah
Salt Lake City, Utah, United States
St. Joseph Cancer Center
Bellingham, Washington, United States
Olympic Hematology and Oncology
Bremerton, Washington, United States
Skagit Valley Hospital Cancer Care Center
Mount Vernon, Washington, United States
Fred Hutchinson Cancer Research Center
Seattle, Washington, United States
Group Health Central Hospital
Seattle, Washington, United States
Harborview Medical Center
Seattle, Washington, United States
Minor and James Medical, Pllc
Seattle, Washington, United States
Polyclinic First Hill
Seattle, Washington, United States
Swedish Cancer Institute at Swedish Medical Center - First Hill Campus
Seattle, Washington, United States
University Cancer Center at University of Washington Medical Center
Seattle, Washington, United States
North Puget Oncology at United General Hospital
Sedro-Woolley, Washington, United States
Cancer Care Northwest - Spokane South
Spokane, Washington, United States
Wenatchee Valley Medical Center
Wenatchee, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Dec 2004
Primary completion: 30 Apr 2006
Completion: 31 Aug 2009
Last update posted: 18 Jan 2012
Registered enrollment: 60
Registry id: NCT00096213

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.